旧的造血干细胞仍然有能力重建一个年轻的B细胞系统,该系统对基于蛋白质的疫苗接种有很高的反应
Paul Kunath1, Dominik Pflumm1, Bettina Moehrle2
1Department of Internal Medicine I, University Hospital of Ulm, Ulm, Germany.
Immunity & ageing : I & A
|April 5, 2025
概括
旧的造血干细胞 (HSC) 可以在年轻小鼠中重建年轻的B细胞系统,在接种疫苗后有效地产生抗体. 这表明与年龄相关的因素,而不是HSC本身,主要影响B细胞在衰老中的功能.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 衰老研究研究 衰老研究
背景情况:
- 衰老会减少CD19+B细胞,并损害抗体反应,特别是针对SARS-CoV-2等疫苗的抗体反应.
- 与年龄相关的B细胞 (ABC) 随着年龄的增长而积累,可能会影响免疫功能.
- 了解老年系统中新的B细胞发育对于改善免疫反应至关重要.
研究的目的:
- 调查旧的造血干细胞 (HSCs) 的潜力,以重建一个功能性的B细胞系统.
- 在一个年轻的接受者环境中,比较年轻与老的B细胞发育和疫苗反应.
- 为了确定HSC或骨髓环境中与年龄相关的变化是否主要驱动B细胞衰老.
主要方法:
- 移植的年轻 (DY-HSC) 和老 (DO-HSC) 供体HSC进入年轻的T细胞和B细胞缺乏RAG1-/-小鼠.
- 评估B细胞复制,包括CD19+B细胞和年龄相关B细胞 (ABC).
- 用SARS-CoV-2尖峰 (S) 蛋白疫苗接种疫苗的小鼠,并测量了抗体标位和中和活性.
主要成果:
- DO-HSCs和DY-HSCs表现出类似的移植,但DO-HSCs重建的CD19+B细胞较少.
- 年轻和老的HSC接受者都开发了最小的ABCs,表明一个年轻的B细胞环境.
- 在DO-HSC和DY-HSC宿主中,SARS-CoV-2 S疫苗诱导了类似的高IgG+抗体标位和中和.
结论:
- 旧的HSC可以在年轻的环境中重建一个功能性,年轻的B细胞系统.
- 在接种疫苗时,由旧的HSC重建的B细胞系统有效地产生抗原特异性抗体.
- 主体环境中的与年龄相关的因素,而不是内在的HSC缺陷,可能会导致B细胞衰老和免疫力受损.
相关概念视频
01:23Cells of the Adaptive Immune Response
694
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
694
01:24B Cell Activation and Differentiation
1.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.3K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:51Vaccinations
43.1K
Overview
43.1K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K